Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. - Klement P; Fiedler W; Gabdoulline R; Dallmann LK; Wienecke CP; Schiller J; Kandziora C; Teich K; Heida B; Büttner K; Brandes M; Funke C; et al. (Annals of hematology, 2023)